COVID-19 leads to deterioration of glucose control in patients with diabetes mellitus, likely through direct virus-mediated β-cell injury, cytokine-induced insulin resistance and hypokalemia-related inhibition of insulin secretion. Here, INS is linked to Insulin resistance.